Health Canada approves Essure:
This article was originally published in Clinica
The third-generation Essure birth control system developed by Conceptus has been approved for sale in Canada. The Mountain View, California company said that the system incorporates modifications to facilitate implantation of the device. In addition, hysteroscopic visualisation of the implant and placement markers has been significantly improved. A new DryFlow Introducer, which alleviates distension fluid loss - a major safety concern of hysteroscopists - is packaged with the product. The device is now approved for sale in Canada, the US, Mexico, Central and South America, New Zealand, Australia and Europe.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.